A single dose of 500 mg/d of valproic acid can be effective in Juvenile Myoclonic Epilepsy;Traitement de l'Epilepsie Myoclonique Juvenile par des faibles doses de valproate de sodium

Revue Neurologique

Volumn 152, Issue 11, 1996, Pages 708-710

  De Toffol, B ^a   Autret, A ^a  

^a CHU BRETONNEAU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VALPROIC ACID; ANTICONVULSIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MYOCLONUS EPILEPSY; ORAL DRUG ADMINISTRATION; SCHOOL CHILD; SLOW RELEASE FORMULATION; AGED; CASE REPORT; DOSE RESPONSE; MIDDLE AGED; PROSPECTIVE STUDY;

ADULT; AGED; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSIES, MYOCLONIC; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VALPROIC ACID;

EID: 0029823445     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Commission on classification and terminology of the international league against epilepsy (1989). Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia, 30 : 389-399.
2. DAVIS R., PETERS D.H., MCTAVISCH D. (1994). Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy. Drugs, 47 : 332-372.
3. JANZ D. (1985). Epilepsy with impulsive petit mal (Juvenile Myoclonic Epilepsy). Acta Neurol Scand, 72 : 449-459.
4. LOISEAU P., DUCHÉ B. (1990). L'épilepsie myoclonique juvénile. Rev Neurol, 146 : 719-725.
5. PANAYIOTOPOULOS C.P., OBEID T., TAHAN A.R. (1994). Juvenile Myoclonic Epilepsy : a 5-year prospective study. Epilepsia, 35 : 285-296.
6. TOUCHON J. (1982). Effect of awakening on epileptic activity in primary generalized myoclonic epilepsy. In : Sterman M.B., Shouse M.N., Passouant P. (eds). Sleep and Epilepsy, pp. 239-248. Academic Press, New York.